Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : INCY crawled time : 20:00 save search
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: 3.51%
H: 9.56%
C: 9.56%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.52%
H: 1.38%
C: 1.11%
business update financial results
Alpenglow Biosciences presents the 3D Spatial Summit, an inaugural event for the field of 3D Spatial Biology to take place on September 21, 2023 in Cambridge, Massachusetts
Published: 2023-08-29 (Crawled : 20:00) - biospace.com/
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.02%
H: 1.21%
C: -0.35%
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma
Published: 2023-06-27 (Crawled : 20:00) - prnewswire.com
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.2%
H: 0.92%
C: 0.48%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.14%
H: 1.22%
C: 0.41%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: -1.66%
approved therapy
Alopecia Areata Market to Show Positive Growth at a CAGR of 26.3% During the Study Period (2019-2032), Estimates DelveInsight
Published: 2023-06-19 (Crawled : 20:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.41%
H: 2.02%
C: 1.37%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: 0.0%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: -2.63%
positive show growth study market
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
Published: 2023-06-12 (Crawled : 20:00) - globenewswire.com
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.48%
H: 1.44%
C: 0.24%
GLPG | News | $29.47 1.38% 1.36% 120K
|
Health Technology
|
| O: -0.92%
H: 1.29%
C: 0.55%
Zai Lab Announces First Quarter 2023 Financial Results and Corporate Updates
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.21%
H: 0.32%
C: -0.07%
ZLAB | $15.13 0.93% 0.93% 470K
|
Health Technology
|
| O: 4.89%
H: 6.5%
C: 1.13%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.17%
H: 0.07%
C: -0.17%
NVCR | $12.055 1.9% 1.87% 750K
|
Health Technology
|
| O: 1.11%
H: 1.89%
C: 0.97%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -2.41%
H: 5.41%
C: 3.75%
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 1.07%
H: 1.21%
C: 0.62%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.29%
H: 0.07%
C: -1.6%
BPMC | $92.32 1.89% 1.85% 790K
|
Health Technology
|
| O: 1.36%
H: 0.13%
C: -1.89%
results
Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.08%
H: 0.74%
C: -0.07%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: 4.36%
H: 8.41%
C: 5.96%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.85%
H: 1.46%
C: -0.28%
business update financial results
Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents
Published: 2023-04-20 (Crawled : 20:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -12.76%
H: 0.0%
C: 0.0%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.23%
H: 0.87%
C: 0.29%
opzelura approval treatment
Global STAT3 Inhibitors Market & Clinical Trials Outlook 2028: Insight and Analysis on Over 30 Drugs and 20 Companies
Published: 2023-01-27 (Crawled : 20:00) - prnewswire.com
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
| Email alert
Add to watchlist
trials global companies market
AL Amyloidosis Market to Showcase Growth at a CAGR of 7.24% by 2032 | DelveInsight
Published: 2022-10-03 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 8.97%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: 0.0%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.84%
H: 0.81%
C: 0.22%
growth market
Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL
Published: 2021-06-04 (Crawled : 20:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.38%
H: 1.25%
C: -0.76%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 3.74%
H: 3.11%
C: 2.76%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.33%
H: 1.54%
C: 0.19%
treatment phase 2 results als
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.